Natural Product: NPC329847

Natural Product IDNPC329847
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
BGGCSIYMQIZMAZ-DXBOVLASSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 44575575
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0003297] Organic Polymers
      • [CHEMONTID:0003298] Polypeptides

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey BGGCSIYMQIZMAZ-DXBOVLASSA-N
Standard InCHI InChI=1S/C116H179N35O40S6/c1-49(2)31-64-112(187)149-28-17-23-75(149)104(179)145-87(52(7)8)108(183)141-73(115(190)191)48-197-192-43-68-98(173)135-67(42-153)97(172)137-69-44-193-195-46-71(140-111(186)90(55(11)156)146-94(169)61(25-26-84(165)166)128-79(160)35-117)101(176)143-85(50(3)4)106(181)127-37-80(161)124-38-83(164)142-88(53(9)154)109(184)139-70(99(174)133-63(34-78(119)159)95(170)148-91(56(12)157)114(189)151-30-16-22-74(151)103(178)126-40-82(163)130-68)45-194-196-47-72(102(177)147-89(54(10)155)110(185)131-60(21-15-27-122-116(120)121)93(168)132-62(33-77(118)158)92(167)125-39-81(162)129-64)138-107(182)86(51(5)6)144-105(180)76-24-18-29-150(76)113(188)65(134-96(171)66(41-152)136-100(69)175)32-57-36-123-59-20-14-13-19-58(57)59/h13-14,19-20,36,49-56,60-76,85-91,123,152-157H,15-18,21-35,37-48,117H2,1-12H3,(H2,118,158)(H2,119,159)(H,124,161)(H,125,167)(H,126,178)(H,127,181)(H,128,160)(H,129,162)(H,130,163)(H,131,185)(H,132,168)(H,133,174)(H,134,171)(H,135,173)(H,136,175)(H,137,172)(H,138,182)(H,139,184)(H,140,186)(H,141,183)(H,142,164)(H,143,176)(H,144,180)(H,145,179)(H,146,169)(H,147,177)(H,148,170)(H,165,166)(H,190,191)(H4,120,121,122)/t53-,54-,55-,56-,60+,61+,62+,63+,64+,65+,66+,67+,68+,69+,70+,71+,72+,73+,74+,75+,76+,85+,86+,87+,88+,89+,90+,91+/m1/s1
SMILES CC(C)C[C@H]1C(=O)N2CCC[C@H]2C(=N[C@@H](C(C)C)C(=N[C@@H](CSSC[C@H]2C(=N[C@@H](CO)C(=N[C@H]3CSSC[C@@H](C(=N[C@@H](C(C)C)C(=NCC(=NCC(=N[C@@H]([C@@H](C)O)C(=N[C@@H](CSSC[C@@H](C(=N[C@@H]([C@@H](C)O)C(=N[C@@H](CCCNC(=N)N)C(=N[C@@H](CC(=N)O)C(=NCC(=N1)O)O)O)O)O)N=C([C@H](C(C)C)N=C([C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c4ccccc14)N=C([C@H](CO)N=C3O)O)O)O)C(=N[C@@H](CC(=N)O)C(=N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=NCC(=N2)O)O)O)O)O)O)O)O)O)N=C([C@H]([C@@H](C)O)N=C([C@H](CCC(=O)O)N=C(CN)O)O)O)O)O)C(=O)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   2894.14 Volume:   2696.44
?
Van der Waals volume.
Dense:   1.073 LogP:   -8.754
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   -4.66
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.53
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   32.0 Rigid Bonds:   123.0
TPSA:   1263.53
?
Topological Polar Surface Area.
H-Bond Acceptor:   75.0
H-Bond Donor:   44.0 Rings:   9.0
Heavy Atoms:   81.0

MedChem Properties

QED Drug-Likeness Score:   0.013 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   9.801 Fsp3:   0.647
MCE-18:   325.785
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.333 Fluc inhibitor:   0.358
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.341
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.438
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.766 Promiscuous compounds:   0.246

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.122 MDCK Permeability:   -5.492
Pgp-inhibitor:   0.0 Pgp-substrate:   1.0
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   1.0
20% Bioavailability (F20%):   1.0 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.768
Plasma Protein Binding (PPB):   -30.93% Volume Distribution (VD):   -0.964
Fu: 135.977%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.0
BSEP inhibitor:   0.002

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  -4.061 Half-life (T1/2):  10.649

ADMET: Toxicity

hERG Blockers:  0.0 hERG Blockers (10um):  0.0
Human Hepatotoxicity (H-HT):  1.0 Drug-induced Liver Injury (DILI):  1.0
AMES Toxicity:  0.0 Rat Oral Acute Toxicity:  0.166
Maximum Recommended Daily Dose:  0.0 Skin Sensitization:  1.0
Carcinogencity:  0.977 Eye Corrosion:  0.0
Eye Irritation:  0.0 Respiratory Toxicity:  0.026
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  1.0
Hematotoxicity:  0.996 Drug-induced Nephrotoxicity:  1.0
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.0
A549 Cytotoxicity:  0.0 Hek293 Cytotoxicity:  0.0
BCF:   -0.299
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.881
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.521
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.095
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO782 Viola tricolor Species Violaceae Eukaryota n.a. n.a. n.a. DOI[10.1016/S0040-4039(00)90113-8]
NPO782 Viola tricolor Species Violaceae Eukaryota n.a. n.a. n.a. PMID[14987049]
NPO782 Viola tricolor Species Violaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO782 Viola tricolor Species Violaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO782 Viola tricolor Species Violaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO782 Viola tricolor Species Violaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT5192 Cell line U-937/GTB Homo sapiens IC50 = 6000.0 nM PMID[14987049]
NPT389 Cell line RPMI-8226 Homo sapiens IC50 = 3000.0 nM PMID[14987049]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC329847 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9809 High Similarity NPC329855
0.8974 High Similarity NPC486508
0.8868 High Similarity NPC485125
0.858 High Similarity NPC486503
0.7989 Intermediate Similarity NPC479083
0.7802 Intermediate Similarity NPC479082
0.7204 Intermediate Similarity NPC486517
0.7128 Intermediate Similarity NPC486504
0.6935 Remote Similarity NPC329843
0.6596 Remote Similarity NPC485244
0.6505 Remote Similarity NPC486506
0.6505 Remote Similarity NPC485247
0.6505 Remote Similarity NPC486514
0.6486 Remote Similarity NPC477635
0.6461 Remote Similarity NPC485246
0.6409 Remote Similarity NPC485243
0.6398 Remote Similarity NPC486515
0.6333 Remote Similarity NPC485245
0.6312 Remote Similarity NPC485124
0.6202 Remote Similarity NPC480594
0.5989 Remote Similarity NPC320968
0.5938 Remote Similarity NPC489511
0.5784 Remote Similarity NPC486507
0.5773 Remote Similarity NPC484965
0.5753 Remote Similarity NPC477632
0.5699 Remote Similarity NPC484963
0.5668 Remote Similarity NPC486505
0.565 Remote Similarity NPC477633
0.5632 Remote Similarity NPC484964
0.5622 Remote Similarity NPC477634
0.5583 Remote Similarity NPC489512
0.5579 Remote Similarity NPC484365
0.5538 Remote Similarity NPC486513
0.5368 Remote Similarity NPC485115
0.5329 Remote Similarity NPC483985
0.5181 Remote Similarity NPC482981
0.5171 Remote Similarity NPC489216
0.5152 Remote Similarity NPC479141
0.5136 Remote Similarity NPC480533
0.5077 Remote Similarity NPC484078
0.5052 Remote Similarity NPC484364
0.5051 Remote Similarity NPC489217

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC329847 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5115 Remote Similarity NPD7970 Phase 4
0.5115 Remote Similarity NPD7971 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data